Elanco stock heads toward November 6 quarterly results

Published on 10/30/2026 at 20:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Elanco stock is scheduled to report third-quarter results before the U.S. market opens. Analysts expect revenue of USD 1.21 billion.

What investors should watch next

Elanco expects third-quarter adjusted EPS of USD 0.190 to USD 0.220.
Full-year 2026 adjusted EPS guidance stands at USD 1.100 to USD 1.160.

ELAN, US28414H1032, Illustration mit AI erstellt.

Elanco Animal Health is scheduled to release its third-quarter 2026 results before the U.S. market opens on Friday, November 6. MarketBeat reported that the company has also scheduled an earnings call for 8:00 a.m. Eastern Time that day.

Analysts expect Elanco to post earnings of USD 0.2028 per share and revenue of USD 1.21 billion for the quarter, according to MarketBeat. The company has set third-quarter adjusted EPS guidance at USD 0.190 to USD 0.220 and full-year 2026 guidance at USD 1.100 to USD 1.160.

Recent results set the comparison

Elanco last reported on August 5. Adjusted earnings reached USD 0.34 per share, above the USD 0.27 consensus estimate, while revenue rose 10.2 percent year over year to USD 1.37 billion. The upcoming release will show whether that momentum continued into the third quarter.

MarketBeat said analysts held a Moderate Buy consensus and an average price target of USD 29.33. Those assessments reflect expectations for the business and should not be treated as a forecast of the share price.

The real-time quote of Elanco Animal Health stock was EUR 20.63 on Lang & Schwarz at 20:35 CET on Friday, October 30, 2026.